Per Briand

2.3k total citations · 1 hit paper
57 papers, 2.0k citations indexed

About

Per Briand is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Per Briand has authored 57 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 27 papers in Genetics and 23 papers in Oncology. Recurrent topics in Per Briand's work include Estrogen and related hormone effects (21 papers), Cancer Cells and Metastasis (13 papers) and HER2/EGFR in Cancer Research (7 papers). Per Briand is often cited by papers focused on Estrogen and related hormone effects (21 papers), Cancer Cells and Metastasis (13 papers) and HER2/EGFR in Cancer Research (7 papers). Per Briand collaborates with scholars based in Denmark, France and United States. Per Briand's co-authors include Anne E. Lykkesfeldt, Ole W. Petersen, Bo van Deurs, Mogens Winkel Madsen, Ruth Lupu, Piotr Janik, Fei Wang, Valerie M. Weaver, N. R. Hartmann and Shoukat Dedhar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

Per Briand

56 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology

1998 535 citations Ole W. Petersen, Per Briand et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Per Briand Denmark	23	956	894	535	372	352	57	2.0k
Jeffrey A. Torri United States	10	811 0.8×	592 0.7×	163 0.3×	383 1.0×	292 0.8×	13	1.4k
Francisca Maurer Switzerland	10	1.4k 1.4×	900 1.0×	142 0.3×	208 0.6×	238 0.7×	15	2.1k
Alicia S. Chung United States	11	1.4k 1.5×	798 0.9×	213 0.4×	517 1.4×	170 0.5×	16	2.3k
Ilya G. Serebriiskii United States	33	2.5k 2.6×	1.0k 1.1×	297 0.6×	488 1.3×	730 2.1×	97	3.8k
Jean Gudas United States	25	1.3k 1.3×	945 1.1×	399 0.7×	404 1.1×	161 0.5×	44	2.1k
Xiaochun Xu United States	19	1.3k 1.3×	505 0.6×	341 0.6×	507 1.4×	240 0.7×	36	2.0k
Kozłowski Jm United States	3	844 0.9×	565 0.6×	70 0.1×	504 1.4×	266 0.8×	9	1.7k
Vimla Band United States	17	1.1k 1.1×	618 0.7×	183 0.3×	351 0.9×	186 0.5×	23	1.7k
J.G. Collard Netherlands	24	1.2k 1.2×	297 0.3×	140 0.3×	162 0.4×	344 1.0×	45	1.7k
Peter J. Coopman France	23	1.5k 1.5×	460 0.5×	142 0.3×	448 1.2×	613 1.7×	51	2.3k

Countries citing papers authored by Per Briand

Since Specialization

Citations

This map shows the geographic impact of Per Briand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Briand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Briand more than expected).

Fields of papers citing papers by Per Briand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Briand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Briand. The network helps show where Per Briand may publish in the future.

Co-authorship network of co-authors of Per Briand

This figure shows the co-authorship network connecting the top 25 collaborators of Per Briand. A scholar is included among the top collaborators of Per Briand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Briand. Per Briand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jensen, Janne, et al.. (2003). Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium. The Journal of Steroid Biochemistry and Molecular Biology. 84(4). 469–478. 22 indexed citations

Lundholt, Betina Kerstin, Per Briand, & Anne E. Lykkesfeldt. (2001). Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways. Breast Cancer Research and Treatment. 67(3). 199–214. 46 indexed citations

Briand, Per & Anne E. Lykkesfeldt. (2001). An in vitro Model of Human Breast Carcinogenesis: Epigenetic Aspects. Breast Cancer Research and Treatment. 65(2). 179–187. 23 indexed citations

Villadsen, René, Kirsten Vang Nielsen, Lars Bolund, & Per Briand. (2000). Complete Loss of Wild-Type TP53 in a Nontransformed Human Epithelial Cell Line Is Preceded by a Phase During Which a Heterozygous TP53 Mutant Effectively Outgrows the Homozygous Wild-Type Cells. Cancer Genetics and Cytogenetics. 116(1). 28–34. 4 indexed citations

Wahl, M, Patricia M. Pooler, Per Briand, Dennis B. Leeper, & Charles S. Owen. (2000). Intracellular pH regulation in a nonmalignant and a derived malignant human breast cell line. Journal of Cellular Physiology. 183(3). 373–380. 32 indexed citations

Briand, Per, Betina Kerstin Lundholt, Jan Skouv, & Anne E. Lykkesfeldt. (1999). Growth response of breast epithelial cells to estrogen is influenced by EGF. Molecular and Cellular Endocrinology. 153(1-2). 1–9. 11 indexed citations

Lundholt, Betina Kerstin, Mogens Winkel Madsen, Anne E. Lykkesfeldt, Ole W. Petersen, & Per Briand. (1996). Characterization of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER) cDNA. Molecular and Cellular Endocrinology. 119(1). 47–59. 20 indexed citations

Lykkesfeldt, Anne E., S. S. Larsen, & Per Briand. (1995). Human breast cancer cell lines resistant to pure anti‐estrogens are sensitive to tamoxifen treatment. International Journal of Cancer. 61(4). 529–534. 72 indexed citations

Balslev, I., Ib Jarle Christensen, Birgitte Rasmussen, et al.. (1994). Flow cytometric DNA ploidy defines patients with poor prognosis in node‐negative breast cancer. International Journal of Cancer. 56(1). 16–25. 39 indexed citations

10.

Madsen, Mogens Winkel, et al.. (1994). Gradual Selection of a Cellular Clone Presenting a Mutation at Codon 179 of the p53 Gene during Establishment of the Immortalized Human Breast Epithelial Cell Line HMT-3522. Experimental Cell Research. 215(2). 380–385. 34 indexed citations

11.

Nielsen, Kirsten Vang, Mogens Winkel Madsen, & Per Briand. (1994). In vitro karyotype evolution and cytogenetic instability in the non-tumorigenic human breast epithelial cell line HMT-3522. Cancer Genetics and Cytogenetics. 78(2). 189–199. 28 indexed citations

12.

Madsen, Mogens Winkel & Per Briand. (1990). Relationship between tumorigenicity, in vitro invasiveness, and plasminogen activator production of human breast cell lines. European Journal of Cancer and Clinical Oncology. 26(7). 793–797. 23 indexed citations

13.

Lykkesfeldt, Anne E., Inga Laursen, & Per Briand. (1989). Regulation of the secretion of proteins synthesized by the human breast cancer cell line, MCF-7. Molecular and Cellular Endocrinology. 62(2). 287–296. 16 indexed citations

14.

Nielsen, Kirsten Vang & Per Briand. (1989). Cytogenetic analysis of in vitro karyotype evolution in a cell line established from nonmalignant human mammary epithelium. Cancer Genetics and Cytogenetics. 39(1). 103–118. 24 indexed citations

15.

Pasanen, Markku, Simon Stacey, Anne E. Lykkesfeldt, et al.. (1988). Induction of cytochrome P-450IA1 gene expression in human breast tumour cell lines. Chemico-Biological Interactions. 66(3-4). 223–232. 21 indexed citations

16.

Ellemann, Karsten, et al.. (1988). Glucocorticoid receptors in glioblastoma multiforme: A new approach to antineoplastic glucocorticoid therapy. Acta Neurochirurgica. 93(1-2). 6–9. 9 indexed citations

17.

Lykkesfeldt, A. E., et al.. (1988). Reversible inhibitory activity of sera from breast cancer patients on oestrogen. European Journal of Cancer and Clinical Oncology. 24(10). 1647–1653. 4 indexed citations

18.

Vlatkovic, Ljiljana, Anne E. Lykkesfeldt, K Hou-Jensen, & Per Briand. (1987). Comparison of the immunocytochemical assay (ER-ICA) and the biochemical assay for estrogen receptor in human breast cancer cell lines. European Journal of Cancer and Clinical Oncology. 23(6). 755–760. 6 indexed citations

19.

Petersen, Ole W., Per Briand, & Bo van Deurs. (1984). IDENTIFICATION OF MALIGNANT CELLS IN PRIMARY MONOLAYER CULTURES OF HUMAN BREAST TUMORS. Acta Pathologica Microbiologica Scandinavica Series A Pathology. 92A(1-6). 103–112. 3 indexed citations

20.

Briand, Per, et al.. (1973). Enzyme patterns of glucose catabolism in hormone-dependent and -independent mammary tumours of GR mice. European Journal of Cancer (1965). 9(10). 763–770. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact